Investment Québec, The Pallinghurst Group and Orion Mine Finance total acquisition of Nemaska Lithium

 

S

Global fuel cell market for industrial and military applications Business Continuity Plan 2020-2024 for the new Technavio standard

Schall, a national shareholder rights litigation firm, announces it is investigating claims on behalf of Cabot Oil

If you are a shareholder, click to participate.

We also inspired you to contact Brian Schall of Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. the signature’s online page on www. schallfirm. com, or by email to [email protected].

The law firm Schall represents investors from all over the world and specializes in securities movements and shareholder rights litigation.

This press release may be an advertisement for attorneys in certain jurisdictions under applicable ethical laws and standards.

ProShares, a leading ETF PROVIDER, announced that it will move NYSE Arca ProShares’ directory of 4 ETFs to the Cboe BZX Stock Exchange around December 16, 2020.

Existing shareholders of these ProShares ETFs are not required to take action and the change to trading of the fund’s shares is not expected.

The following ETFs are transferred to the Cboe BZX exchange:

About ProShares

ProShares has been at the forefront of the ETF revolution since 2006. ProShares offers one of the largest ETF ranges, with over $40 billion in assets. The company is a leader in methods such as dividend growth, interest rate-backed bonds and ETF-based investments (leveraged and reversed). ProShares continues to innovate with products that offer investors strategic and tactical opportunities to manage threats and returns.

December 1 2020

PLEASE NOTE: Funds are referenced as opposed to a VIX Futures Index. Funds are not referenced as opposed to the widely referenced Cboe volatility index, commonly known as VIX. ) or part of the opposite (-0. 5x) of VIX PERFORMANCE, as the case may be.

There are risks related to investing, adding the loss of capital imaginable, the Volatility ProShares ETFs are not diversified and all bring safe dangers, adding dangers related to the use of derivatives (swap contracts, futures and similar instruments), an imperfect correlation of benchmarks, leverage and fluctuations in market prices, all of which can create volatility and minimize performance. See full summary and package inserts for a more complete description of hazards.

There are significant dangers related to investing in ETFs compared to VIX Futures Indices, and ProShares Volatility ETFs are not suitable for all investors. VIX futures indices can be highly volatile and the referred ETFs can suffer significant losses. potentially lose the full price of your investment in periods as short as a day. Many points can contribute to the volatility of VIX futures indices, which include, but are not limited to: economic, political or regulatory occasions when the SX point

ProShares Trust II is a group of raw fabrics as explained in the Commodity Exchange Act and applicable CFTC regulations. ProShare Capital Management LLC is the trust sponsor and product group operator (CPO). The sponsor is registered as a CPO with the CFTC and is a member of the NFA. Neither these ETFs nor ProShares Trust II are investment companies through the Investment Companies Act 1940 and have no protection.

“Standard

This data must be accompanied by or preceded by an existing ProShares Trust II prospectus.

Clinigen Group plc (AIM: CLIN, ‘Clinigen’), the global pharmaceutical company, has introduced its operations in Malaysia with a workplace in Kuala Lumpur. The new workplace is a component of Clinigens’ strategy to expand its presence in Southeast Asia, a vital market for the Group.

The Group’s strategy in Malaysia is to become the selection provider for the procurement and delivery of medicines to its customers, offering more infrastructure to its project to bring the right medicine to the right patient at the right time.

The immediate goal is to expand access to unlicensed medicines by expanding the scope of Group Unlicensed Medicines’ patented source agreements and on-demand service, as well as providing Clinigens Clinical to its customers.

In the long term, the presence of Clinigens will increase its ability to obtain and distribute products from the Group’s authorized drug portfolio and make Clinigen a more excited spouse for pharmaceutical corporations looking to market their products outdoors in their original geographic areas, Clinigens’ regulatory experience.

Clinigen employs more than 1,150 foreign people in 14 foreign locations. The opening of the extra Malasio expands its foreign source chain and operational network.

Shaun Chilton, executive leader of the group, Clinigen, said:

We continue to occupy our market leadership positions in the source and distribution of unauthorized medicines in key geographic areas, which will stimulate sustained biological expansion and help address patients’ dissatisfied desires to access critical medicines.

Pharmaceutical and biotechnology companies are looking for specialized partners to paint with them in Asia. Opening our workplace in Malaysia will offer Clinigen greater opportunities to offer its consumers worldwide and locally.

Notes for editors

About the Clinigen Group

Clinigen Group plc (AIM: CLIN) is a global pharmaceutical and corporate company with an exclusive mix of corporations focused on providing moral access to medicines. Your project is to deliver the right drug to the right patient at the right time in 3 global drug supply spaces; Unauthorized and authorized drugs. The Group has locations in North America, Europe, Africa and Asia Pacific.

Clinigen now has more than 1,150 workers on five continents in 14 countries, with uniform centres of origin and distribution and centres of excellence in key regions of long-term growth. The Group works with 21 of the 25 largest pharmaceutical companies; interacting with more than 18,000 registered users in more than 115 countries, sending around 6. 5 million games consistent with the year.

For more information about Clinigen, visit www. clinigengroup. com

Schall, a national shareholder rights litigation company, announces that it is investigating claims on behalf of InvestorsArray.

ProShares, one of the leading ETF providers, announced the move of NYSEArray’s 4 ETF Directory of ProShares.

LG Chem Life Sciences (LG Chem), a department of LG Chem, and TransThera Biosciences Co. Ltd. (TransThera), a biotechnology in the levelArray. .

Clinigen Group plc (AIM: CLIN, ‘Clinigen’), the global company and pharmaceutical company, has introduced its business in Malaysia with an Array workplace.

Templeton Global Income Fund [NYSE: GIM] today announced a revenue distribution consistent with the month of the net investment source of $0. 0170 consistent with share, payableArray. .

The Templeton Emerging Markets Income Fund [NYSE: TEI] today announced a revenue distribution consistent with the month of the net income investment source of $0. 0412 consistent with the Array stock.

Virgin Galactic Holdings, Inc. (NYSE: SPCE), announced its new flight window as it suspended flight arrangements for the area in reaction to Array.

Starting today, Florida’s audience of the twelfth largest television market in the country will have a long-term idea as a local . . .

JBG SMITH (NYSE: JBGS), one of the leading owners and developers of mixed-use homes in the Washington, D. C. market, has arrived at Array. .

Montreal-based MIMs My Intelligent Machines (MIMs) is a leader in synthetic intelligence and systems biology. MIMs supplies pharmaceutical companies with Array.

Mandatory cookies are surely for the proper functioning of the site. This category includes only cookies that provide the fundamental capability and security features of the website. These cookies do not purchase any non-public information.

Leave a Comment

Your email address will not be published. Required fields are marked *